Study guide

12.3 Mixed Arterial-Venous Disease and Compression Safety

WOCNCB Certified Wound Care Nurse CWCN

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CWCN Exam Facts 1.2 Eligibility: Traditional, Experiential, and WTA-C Credit 1.3 Fees, Retakes, Recertification, and Test Strategy

2 Skin Biology, History & Systemic Factors

2.1 Integumentary Anatomy and Skin Barrier 2.2 Healing Phases, Healing vs Non-Healing, and Biofilm 2.3 History, Psychosocial Factors, Nutrition, and Pain 2.4 Systemic Healing Factors and Medications

3 Diagnostics and the Focused Wound Exam

3.1 Vascular, Laboratory, Imaging, and Perfusion Studies 3.2 Wound Measurement, Periwound Signs, and Dermatologic Differentials 3.3 When and How to Culture a Wound

4 Pressure Injury Pathophysiology and Staging

4.1 Pressure Injury Pathophysiology and Risk Tools 4.2 NPIAP Stages 1 through 4 4.3 Unstageable, DTPI, MDRPI, and Mucosal Injuries

5 Lower-Extremity and Special Etiologies

5.1 Venous / LEVD Ulcer Assessment 5.2 Arterial / LEAD Ulcer Assessment and PAD Testing 5.3 Neuropathic Foot Ulcers, Charcot, and Wagner Grading 5.4 Mixed Disease, Atypical, Surgical, Traumatic, and Burn Wounds

6 Prevention and Support Surfaces

6.1 Risk-Based Prevention: Moisture, Nutrition, Mobility, Cognition 6.2 Repositioning, Shear Reduction, and Seating 6.3 Support Surface Types and Selection

7 Offloading, Moisture, and Skin Products

7.1 Offloading and Protective Footwear 7.2 MASD/IAD, MARSI Prevention, and Skin Care Products 7.3 Friction, Heel Protection, and Preventing Treatment Complications

8 Wound-Care Principles, Pain, and Studies

8.1 Moisture Balance, Dead Space, and Periwound Protection 8.2 Recommending Pain Management Modalities 8.3 Obtaining Cultures and Recommending Studies

9 Cleansing and Wound Bed Preparation

9.1 Wound Cleansing Regimens 9.2 TIME: Infection, Moisture, and Edge Optimization 9.3 Chemical Cauterization Indications

10 Debridement Modalities

10.1 Debridement Types, Indications, and Contraindications 10.2 Conservative Sharp vs Surgical/Excisional Debridement 10.3 Autolytic, Enzymatic, Biological, and Mechanical Debridement

11 Topical Therapies

11.1 Hydrating Dressings: Hydrogels, Films, Hydrocolloids 11.2 Absorbent Dressings: Foams, Alginates, Hydrofibers 11.3 Antimicrobials, Odor Control, and Periwound Integrity

12 Compression Therapy

12.1 Compression Types, Indications, and Contraindications 12.2 Static vs Dynamic Compression Application 12.3 Mixed Arterial-Venous Disease and Compression Safety

13 Advanced and Adjunctive Therapies

13.1 Negative Pressure Wound Therapy 13.2 HBOT, Bioengineered Tissue, and Leech Therapy 13.3 Hydrotherapy, Pulsed Lavage, Mist, Maggot Therapy, and Total Contact Casting

14 Patient-Centered Goals

14.1 Patient-Centered Care, Access, and Cultural Beliefs 14.2 Preventive, Palliative, Maintenance, and Curative Goals 14.3 Writing Patient-Focused Skin and Wound Goals

15 Evaluation, Modification, and Documentation

15.1 Evaluating Treatment Effectiveness 15.2 Interpreting Response and Modifying the Plan 15.3 Documentation, CMS Quality Context, and Surveillance

16 Patient and Caregiver Education

16.1 Health Literacy, Goals, and Teach-Back 16.2 Educating on Procedures, Skin Care, and Diagnostic Results 16.3 Modifiable Risk Factors and Resource Access

17 Educating Other Clinicians

17.1 Teaching Skin and Wound Principles, Procedures, and Goals 17.2 Infection Control, Repositioning, Moisture, Nutrition, and Trauma Avoidance for Teams 17.3 Recommending Non-Invasive and Invasive Next Steps

18 Collaboration, Referral, and Handoff

18.1 Support, Supply Access, Post-Acute Care, and Service Referrals 18.2 Referring for Studies and Specialty Consults 18.3 Handoff Communication Across Settings

12.3 Mixed Arterial-Venous Disease and Compression Safety

Key Takeaways Explain This Topic AI

Mixed ulcers can look venous (gaiter location, hemosiderin, edema) while the ankle-brachial index is reduced; treat the arterial number, not the stain.

Modified or reduced compression such as 20–30 mmHg or light short-stretch is considered only if rest pain is absent, tissue is viable, and vascular agrees.

Never apply high (about 30–40 mmHg) compression when the ankle-brachial index is under 0.5 or the limb shows severe ischemia.

Stop the wrap for new rest pain, purple toes, or expanding necrosis; document the ABI date and the wrap type so the next clinician is not guessing.

Phlebolymphedema (dorsal foot swelling, Stemmer sign, square toes) often needs higher-skill multilayer inelastic compression and sometimes manual lymphatic drainage, not drugstore 15 mmHg socks alone.

Last updated: September 2026

Mixed disease looks venous until you measure

Mixed arterial-venous ulcers borrow the venous costume: irregular gaiter wound, hemosiderin, lipodermatosclerosis, and edema. The arterial plot twist is a reduced ABI , weak or absent pulses, claudication, delayed capillary refill, dependent rubor, or a cool foot. Independent ExamFinch teaching for CWCN candidates treats the ABI and the ischemic history , not the brown stain, as the compression-safety number. If you wrap every gaiter ulcer at 40 mmHg because it “looks venous,” you will infarct the ones that are mixed.

Obtain a current ABI (and a toe pressure or toe-brachial index when calcification makes the ABI falsely high, as in many people with diabetes). An ABI from three years ago does not clear today’s wrap. Repeat when symptoms change.

Reduced compression is a narrow window

When ABI is about 0.5–0.8 , modified/reduced compression —for example 20–30 mmHg stockings or a light short-stretch with fewer layers—is considered only if rest pain is absent, tissue is viable, and vascular agrees . That sentence has three gates, not one. Vascular input is not optional decoration. Tissue that is already dusky, dry necrotic, or punched-out on the toes is not “viable enough to try 30 mmHg and see.”

What reduced looks like in practice: a two-layer reduced system, a light inelastic wrap without extra elastic on top, or 20–30 mmHg garments—not an Unna boot plus a long-stretch Ace “to make up for PAD.” Adding elastic to inelastic is how reduced becomes accidental high compression. Recheck toes the day of application and at close intervals. Edema that melts overnight can turn a barely tolerable wrap into a tighter cylinder; reduced systems still need reapplication when they slip or when volume falls.

Never high compression on ABI under 0.5

Never apply high therapeutic compression (about 30–40 mmHg) when ABI is under 0.5 or when severe PAD is obvious—rest pain, gangrene, a cold pulseless foot. Protect the limb, keep trauma and tight socks off the toes, and get vascular involved. A venous-looking calf ulcer does not overrule an ischemic ankle number. Light tubular stockinette to hold a dressing is not the same as a four-layer kit; do not let language blur that distinction.

Monitor mixed limbs more closely than straightforward VLU limbs. Pain that is new at rest, toes that turn purple , capillary refill that slows, or expanding necrosis at wound edges or on digits means stop the wrap , leave it off, and escalate. Those are not “give it another day” findings. Mild leftover pitting after a good reduced wrap is not a stop. Stain on the outer cohesive layer is not a stop. Scheduled Unna change in a stable, well-perfused limb is not a stop.

  • Safety check Go Stop / do not start high compression
  • ABI >~0.8 for high dose; 0.5–0.8 only reduced if gates met <0.5 for high compression
  • Pain No ischemic rest pain New rest pain after wrapping
  • Toes Warm, usual color, refill preserved Purple, dusky, cold, delayed refill
  • Tissue Viable, no expanding dry necrosis Expanding necrosis or gangrene
  • Heart Compensated, euvolemic Acute pulmonary edema
  • Infection Controlled or improving on treatment Untreated spreading cellulitis
  • Phlebolymphedema needs more than a 20 mmHg sock

Phlebolymphedema is combined venous hypertension and lymphatic failure. Look for dorsal foot swelling, a positive Stemmer sign (inability to pinch a skin fold at the base of the second toe), square toes, cobblestone or papillomatous skin, and recurrent cellulitis. Standard VLU 20–30 mmHg drugstore socks often fail because the lymphatic component needs a higher-skill plan: short-stretch multilayer inelastic bandaging, well-fitted inelastic adjustable garments, and often manual lymphatic drainage (MLD) from a clinician trained in complete decongestive therapy. Refer rather than endlessly escalating elastic Ace wraps. Compression remains part of the plan; the class and the skill level change.

Document ABI date and wrap type

Write down the ABI value and the date it was measured , the wrap class (short-stretch three-layer, reduced two-layer, 20–30 mmHg stocking, IPC setting), who applied it, the toe check, and what you told the person about removal triggers. The night nurse cannot guess whether yesterday’s wrap was high or reduced. If vascular asked for reduced compression only, that instruction belongs in the note, not in someone’s memory.

Clinical scenario

A 74-year-old has a medial gaiter ulcer, hemosiderin, and edema. The foot is cooler than the other side. ABI today is 0.62 . There is no rest pain, wound bed tissue is viable, and vascular agrees to a trial of reduced compression. A clinician instead applies a standard four-layer kit aimed at 40 mmHg because “it looks like a venous ulcer.” Overnight the person develops rest pain and purple toes. Independent ExamFinch teaching for CWCN candidates calls this a safety miss: mixed disease was visible in the ABI, high compression was contraindicated, and new rest pain plus purple toes is a reason to remove the wrap immediately and escalate. The correct first plan was light short-stretch or 20–30 mmHg with close monitoring—not a full therapeutic venous kit. If ABI had been 0.44 , even reduced high-skill compression would wait on vascular; never high-dose wrap that foot.